Institutional members access full text with Ovid®

Share this article on:

The Management of Depression During Pregnancy: A Report From the American Psychiatric Association and the American College of Obstetricians and Gynecologists

Yonkers, Kimberly A. MD; Lockwood, Charles J. MD; Wisner, Katherine MD, MS

doi: 10.1097/AOG.0b013e3181c8b2bf
Departments: Letters to the Editor

Departments of Psychiatry and Obstetrics, Gynecology and Reproductive Sciences, Yale School of Medicine, New Haven, Connecticut (Yonkers)

Department of Obstetrics, Gynecology and Reproductive Sciences, Yale School of Medicine, New Haven, Connecticut (Lockwood)

Departments of Psychiatry, Obstetrics and Gynecology and Reproductive Sciences, Epidemiology, and Women’s Studies, Western Psychiatric Institute and Clinic, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania (Wisner)

Financial Disclosure: Dr. Yonkers received medications from Pfizer (New York, NY) to conduct a National Institute on Mental Health ([NIMH] Bethesda, MD) study and funding from Eli Lilly Co. [Indianapolis, IN])to conduct an investigator-initiated trial. She has received author royalties from UptoDate (http://www.uptodate.com) and has received study support from the National Institute on Drug Abuse, the NIMH, and the National Institute of Child Health and Human Development ([NICHD] Bethesda, MD). Dr. Wisner serves on the advisory board at Eli Lilly Co. and has received a donation of active and placebo transdermal estradiol patches for an NIMH funded study from Novartis (Basel, Switzerland). She has also served on the speakers bureau for GlaxoSmithKline (Philadelphia, PA), and has received a research grant from Pfizer. The other author did not report any potential conflicts of interest.

© 2010 by The American College of Obstetricians and Gynecologists.